WAKO Poland recognised by the Polish Olympic Committee

Details

Published on Thursday, 05 October 2017 16:06

On 26th September 2017 Polish Kickboxing Federation (WAKO Poland) became officially a member of the Polish Olympic Committee.

Mr. Piotr Siegoczynski, President of the Polish Kickboxing Federation, comments:
"Our long-term aspirations to gain membership of POC have become a reality. Polish Kickboxing Federation has been recognized by Polish Ministry of Sport since 1989. It took a long time to gain a change in perception of non-Olympic sports in Poland and join the Olympic family. To achieve this goal we have organized many activities in Poland and internationally. We owe a lot to the success of The World Games in Poland, Wroclaw 2017. Our efforts also included an important visit of WAKO President, Mr. Borislav Pelevic, to the Polish Olympic Committee in January 2017. WAKO President met with the Vice-President of the Polish Olympic Committee and a Polish member of the IOC – Ms. Irena Szewinska. On that occasion, Ms. Szewinska supported the WAKO application to the IOC."

President of WAKO (IF) Mr. Borislav Pelevic and WAKO Europe President Mr. Roy Baker jointly congratulate the Polish federation for this very important and deserved achievement.

WAKO Europe President Mr. Roy Baker said: "It is a true sign of the commitment and development of the sport in Poland under its leadership. We are delighted for this positive move for the sport in Europe."

WADA publishes 2018 List of Prohibited Substances and Methods

Details

Published on Thursday, 05 October 2017 15:51

Montreal, 29 September 2017 – Today, the World Anti-Doping Agency (WADA) publishes the 2018 List of Prohibited Substances and Methods (List); along with, the 2018 Summary of Major Modifications and Explanatory Notes. The List, which was approved by WADA’s Executive Committee on 24 September 2017, comes into force on 1 January 2018.The List, which is one of five International Standards that are mandatory for all Signatories of the World Anti-Doping Code (Code), designates what substances and methods are prohibited both in- and out-of-competition; and, which substances are banned in particular sports. 

“WADA is pleased to publish the 2018 Prohibited List,” said WADA President, Sir Craig Reedie. “Updated annually, the List is released three months ahead of taking effect so that all stakeholders -- in particular athletes and their entourage -- have sufficient time to familiarize themselves with the document and its modifications,” Reedie continued. “It is vital that all athletes and entourage take the necessary time to consult the List; and that, they contact their respective anti-doping organizations (ADOs) if they have any doubts as to the status of a substance or method.”

“Annually, the Prohibited List review involves a very extensive stakeholder consultation process over the course of nine months,” said Director General, Olivier Niggli. “In reviewing the List, experts examine such sources as: scientific and medical research; trends; and, intelligence gathered from law enforcement and pharmaceutical companies in order to stay ahead of those that endeavor to cheat the system,” Niggli continued. 

The List’s annual revision process is led by WADA, beginning with an initial meeting in January and concluding with the publication of the List by 1 October. This is an extensive nine-month consultation process that includes WADA’s List Expert Group gathering information; circulating a draft List amongst stakeholders; taking their submissions into consideration and revising the draft; followed by, review by the Agency’s Health, Medical and Research (HMR) Committee. The HMR Committee then makes its recommendation to WADA’s Executive Committee that approves the List during its September meeting. For a substance or method to be added to the List, it must be determined that it meets two of the following three criteria: 1. it has the potential to enhance or enhances sport performance; 2. it represents an actual or potential health risk to the athletes; or, 3. it violates the spirit of sport.

It should be noted that, for athletes who have a legitimate medical reason for using a prohibited substance or method that is on the List, they may be accommodated if they meet the criteria outlined in the International Standard for Therapeutic Use Exemptions (ISTUE). The TUE process has overwhelming acceptance from athletes, physicians and anti-doping stakeholders worldwide.

To view the changes made in the 2018 Prohibited List as compared to the 2017 version, please see the 2018 Summary of Major Modifications and Explanatory Notes.

Languages and Formats

As of today, the 2018 Prohibited List, the Summary of Modifications, and the 2018 Monitoring Program are available for download on WADA’s website in English and French. Spanish will follow shortly. 

Stakeholders wishing to translate the List into other languages are kindly asked to signal their interest at , by 27 October. If interested, WADA would provide the necessary files; and, once the translation is finalized, would make the List available on the Agency’s website.
 
The List’s mobile-friendly digital edition will go live 1 January 2018. (French version below)
L’AMA PUBLIE LA LISTE DES SUBSTANCES ET MÉTHODES INTERDITES 2018

The List, which is one of five International Standards that are mandatory for all Signatories of the World Anti-Doping Code (Code), designates what substances and methods are prohibited both in- and out-of-competition; and, which substances are banned in particular sports. 

“WADA is pleased to publish the 2018 Prohibited List,” said WADA President, Sir Craig Reedie. “Updated annually, the List is released three months ahead of taking effect so that all stakeholders -- in particular athletes and their entourage -- have sufficient time to familiarize themselves with the document and its modifications,” Reedie continued. “It is vital that all athletes and entourage take the necessary time to consult the List; and that, they contact their respective anti-doping organizations (ADOs) if they have any doubts as to the status of a substance or method.”

“Annually, the Prohibited List review involves a very extensive stakeholder consultation process over the course of nine months,” said Director General, Olivier Niggli. “In reviewing the List, experts examine such sources as: scientific and medical research; trends; and, intelligence gathered from law enforcement and pharmaceutical companies in order to stay ahead of those that endeavor to cheat the system,” Niggli continued. 

The List’s annual revision process is led by WADA, beginning with an initial meeting in January and concluding with the publication of the List by 1 October. This is an extensive nine-month consultation process that includes WADA’s List Expert Group gathering information; circulating a draft List amongst stakeholders; taking their submissions into consideration and revising the draft; followed by, review by the Agency’s Health, Medical and Research (HMR) Committee. The HMR Committee then makes its recommendation to WADA’s Executive Committee that approves the List during its September meeting. For a substance or method to be added to the List, it must be determined that it meets two of the following three criteria: 1. it has the potential to enhance or enhances sport performance; 2. it represents an actual or potential health risk to the athletes; or, 3. it violates the spirit of sport.

It should be noted that, for athletes who have a legitimate medical reason for using a prohibited substance or method that is on the List, they may be accommodated if they meet the criteria outlined in the International Standard for Therapeutic Use Exemptions (ISTUE). The TUE process has overwhelming acceptance from athletes, physicians and anti-doping stakeholders worldwide.

To view the changes made in the 2018 Prohibited List as compared to the 2017 version, please see the 2018 Summary of Major Modifications and Explanatory Notes.

Languages and Formats

As of today, the 2018 Prohibited List, the Summary of Modifications, and the 2018 Monitoring Program are available for download on WADA’s website in English and French. Spanish will follow shortly. 

Stakeholders wishing to translate the List into other languages are kindly asked to signal their interest at , by 27 October. If interested, WADA would provide the necessary files; and, once the translation is finalized, would make the List available on the Agency’s website.
 
The List’s mobile-friendly digital edition will go live 1 January 2018.

(French version is in read more section of article)

Read more: WADA publishes 2018 List of Prohibited Substances and Methods

WADA Executive Committee focuses on long-term budget plans, compliance monitoring and its global HQ

Details

Published on Monday, 25 September 2017 18:03

The Committee also approved the 2018 Prohibited List

Paris, France, 24 September 2017 – Today, the World Anti-Doping Agency (WADA) held an Executive Committee Meeting in Paris, France. The 12-member Committee is WADA's ultimate policy-making body, which is composed equally of representatives from the Olympic Movement and Governments.
 
While the Executive Committee approved the 2018 List of Prohibited Substances and Methods (which will be published before 1 October 2017) and received reports from the Agency’s Standing Committee Chairs, the full-day meeting primarily focused on finance, the future host city of WADA’s global headquarters and Signatories’ compliance with the World Anti-Doping Code (Code).
 
Reflecting on the day’s events, WADA President, Sir Craig Reedie said, “I am very pleased with the robust discussion today between Executive Committee members on a range of topics that are aimed at strengthening clean sport. Important decisions were taken; while, a number of matters were advanced and, where appropriate, will find their way on to the agenda of WADA’s November Foundation Board.”
 
Finance
 
Director General, Olivier Niggli, opened the meeting by providing an overview on a range of operational topics before members turned their attention to finance. Mr. Niggli explained that, further to WADA’s November 2016 Board meeting, which resulted in a series of recommendations being agreed to strengthen the Agency, management developed a four-year budget (2018-2021) that articulates which core activities must be enhanced from a financial perspective related to: compliance monitoring; intelligence and investigations; the whistleblower program; anti-doping organization (ADO) capacity building; education/social science research; laboratory accreditation; scientific research; and, the Anti-Doping Administration and Management System (ADAMS). Niggli outlined that, based on WADA’s 2017 budget of USD 29.7 million, in order to fulfill the Board’s recommendations, WADA would require a budgetary increase of 8%, 15%, 15% and 5% for 2018 – 2021 respectively.  The Committee agreed that, for 2018, proposals of 8% and 5% would be proposed to the Board with a recommendation of the former. As it relates to 2019 – 2021, Governments requested more time to discuss ways and means of accommodating the longer-term budgetary requirements; and, to bring the longer-term budget plan forward for approval at the May 2018 Board meeting.
 
Niggli then went on to say that, while the four-year budget plan reflects the funding needed to enhance WADA’s core activities, the Agency needs much more in order to ‘Change the Game for Clean Sport’, which is why the Agency is pursuing an additional funding strategy that would target contributions from the likes of corporations, foundations and private donors. The Committee heard a proposal from a group of external experts with backgrounds in management consulting, Biopharma and fundraising that outlined WADA’s aspiration to seek additional funding. The Committee endorsed the proposal that this ambitious strategy be explored further by WADA Management.
 
“For 17 years, WADA has led the charge against doping in sport in an ever changing and complex environment,” said Niggli. “We are proud of what has been accomplished with limited resources but believe that much more can and must be done to ‘Change the Game’ and build confidence and trust in the anti-doping system,” he continued. “The additional funding that we aim to secure through our traditional funders and private sources will dramatically increase WADA’s scale, speed and reach in carrying out its core activities.”
 
WADA Headquarters
 
The Meeting then turned its attention to WADA’s global headquarters; which, has been graciously hosted by Montreal International, on behalf of the Governments of Canada and Quebec, since 2001 when the Agency was first established. The matter was first tabled at the May 2017 Board as a result of Montreal International indicating that Canada wished to renew its 10-year hosting agreement with WADA for a further 10-year period, when the current agreement ends on 31 December 2021. At that time, the Board asked that Montreal International detail their proposal; and, that WADA management assess the cost and impact of undertaking an open tender for a potential new host.
 
Committee Members then welcomed a Canadian delegation -- comprised of Mr. Hubert Bolduc, President and Chief Executive Officer of Montreal International; Mr. Marc Garneau, Minister of Transport, Government of Canada; Christine St-Pierre, Minister of International Relations, Government of Quebec; accompanied by a video appeal by Mr. Denis Coderre, Mayor of Montreal -- to detail their proposal.
 
After thanking the Canadian delegation for their proposal, Committee members asked the Chairman, the Director General and the Vice-President, Ms. Linda Hofstad Helleland, to negotiate an agreement that will be submitted to the Board in November 2017.
 
Compliance
 
The Chair of the Compliance Review Committee (CRC), Jonathan Taylor, and WADA Management outlined the activities conducted by WADA in the area of Code compliance monitoring. This includes, in particular, ongoing support to Anti-Doping Organizations to achieve, maintain or regain Code compliance; the conduct of compliance audits regarding identified Code Signatories; as well as, development of an International Standard for Code Compliance by Signatories.
 
The Executive Committee then heard from WADA Management, which provided a status update regarding the Russian Anti-Doping Agency’s (RUSADA’s) progress on the Roadmap to Code Compliance. WADA has never deviated from the agreed Roadmap, which outlines the reinstatement criteria that RUSADA must fulfill before WADA’s independent CRC would recommend, to WADA’s Board, that they be declared compliant again with the Code. The Committee expressed full support for continued delivery of the Roadmap, which was developed and agreed with RUSADA; as well as, the Ministry of Sport, the National Olympic Committee and the Independent Public Anti-Doping Commission. WADA’s Board declared RUSADA non-compliant in November 2015, following revelations of widespread doping in Russian athletics that were exposed via WADA’s independent Pound Commission. 
 
WADA Management emphasized that, in particular, the following three critical elements remain:

1. That the responsible authorities for anti-doping in Russia must publically accept the reported outcomes of the McLaren Investigation.
2. That the Russian Government must provide access for appropriate entities to the stored urine samples in the Moscow Laboratory. These samples are sealed off due to a Federal investigation.
3. That WADA audits RUSADA; which, will be carried out the week of 25 September 2017.

The CRC will hold a special meeting on 24 October 2017 to hear from WADA’s audit team, and from one of the two WADA Independent Experts in Russia. The CRC will then make a recommendation to the November 2017 Board as to whether or not RUSADA should be reinstated.
 
“Since November 2015, WADA and its partners have been working very hard to rebuild a credible, and sustainable, anti-doping program in Russia that will ensure the protection of clean athletes inside and outside of the country,” said Olivier Niggli. “In parallel, since the independent McLaren Investigation report came out in December 2016 -- which re-confirmed institutionalized manipulation of the doping control process in Russia and identified the athletes that may have benefited -- WADA has been supporting and monitoring International Federations (IFs), and other impacted organizations, as much as possible as it relates to whether or not they can assert anti-doping rule violations (ADRVs) against athletes identified,” he continued.  “We are unwavering in pursuing completion of the Roadmap.”

Among other topics, the Committee:

Was updated on the Independent Testing Authority (ITA) that’s process for appointing the Board is ongoing; and

Approved the funding recommendation of USD 2.9 million for scientific research proposals for 2017.

WADA publishes Reporting Guide to Monitor Testing

Details

Published on Monday, 25 September 2017 10:28

Montreal, 22 September 2017 

Dear colleagues,

The World Anti-Doping Agency (WADA) is pleased to publish the Reporting Guide to Monitor Testing.

On 2 October 2014, WADA published the Technical Document for Sport Specific Analysis (TDSSA), which is intended to ensure that Prohibited Substances within the scope of the TDSSA are subject to an appropriate and consistent level of analysis by all Anti-Doping Organizations (ADOs) that conduct testing in the relevant sports and disciplines. Compliance with the TDSSA is mandatory under article 5.4.1 of the World Anti-Doping Code (Code); and, since 1 January 2016, WADA has been closely monitoring implementation of the TDSSA.

On 1 June 2016, following a decision by WADA’s Executive Committee, it became mandatory for ADOs to enter all Doping Control Forms (DCFs) into the Anti-Doping Administration and Management System (ADAMS) no later than 15 business days after sample collection.

As both TDSSA implementation and entry of DCFs into ADAMS are now mandatory, WADA monitors them closely from a Code compliance perspective, including via the Code Compliance Questionnaire (CCQ). Failure to comply with these requirements can result in a declaration of non-compliance.

WADA developed this new Reporting Guide to Monitor Testing in order to assist ADOs with these compliance requirements. The Guide provides step by step instructions to:

• Generate relevant reports in ADAMS;
• Cross check the data and;
• Take the necessary action to eliminate any data entry errors so that ADOs can monitor their compliance with the TDSSA and DCF entry based on accurate testing data.

Kindly note that enhanced reporting functions will be part of the New Generation ADAMS, which is in development, to simplify the monitoring process in the near future.
 
Should you have any questions about this Guide, please contact us at .
 
Best regards,
 
World Anti-Doping Agency